Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2022 / Cilt: 56 - Sayı: 1

The Efficiency of Fractional Anisotropy, Apparent Diffusion Coefficient, and Contrast Enhancement Index in Liver Fibrosis Staging

Pages
113–118
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Correlation of FA values with fibrosis stage and significant difference in FA values between early-late stage fibrosis patients shows that diffusion tensor imaging can be a promising technique in the staging and follow-up of liver fibrosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Even though magnetic resonance imaging has been described as the most effective imaging method for the diag- nosis of liver fibrosis, an accepted magnetic resonance ımaging (MRI) technique is yet to be defined.
📊
Key Findings & Data:The intraclass correlation coefficient was used to analyze the inter-rater agreements.
💡
Conclusion & Impact:Conclusion: Correlation of FA values with fibrosis stage and significant difference in FA values between early-late stage fibrosis patients shows that diffusion tensor imaging can be a promising technique in the staging and follow-up of liver fibrosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Even though magnetic resonance imaging has been described as the most effective imaging method for the diag- nosis of liver fibrosis, an accepted magnetic resonance ımaging (MRI) technique is yet to be defined. The aim of this study is to determine the efficiency of MRI in the staging of liver fibrosis. Methods: Patients with chronic hepatitis B infection and had upper abdominal MRI with hepatocyte specific contrast agent were evaluated. Twenty-nine patients that had undergone liver biopsy were included in the study. ADC, FA, and signal intensity values of liver parenchyma were measured by two observers and contrast enhancement index (CEI) was calculated as well. Patients were grouped as early (A) and late fibrosis(B) according to Ishak grading system and then the correlations between the stage and MRI findings were analysed. The intraclass correlation coefficient was used to analyze the inter-rater agreements. ADC, FA, and CEI were compared with Student t-test between early and late fibrosis groups. Pearson’s correlation was used to assess the correlation between ADC and FA values. Spearman correlation was used to evaluate the relationship between pathologic fibrosis grade and MRI parameters that were measured. Results: Twenty-two patients were staged as 1 and 2 (group A), seven patients were staged as 3 and above fibrosis(group B). Statisti- cally, there was a strong, negative correlation between the FA values and the degree of fibrosis (r=−0.582, p=0.001). There was no correlation between the CEI and hepatocyte activity index (r=−0.88, p=0.655) and degree of fibrosis (r=0.0001, p=0.997). In terms of FA values, there was a statistically significant difference between two groups (group A=0.429 ± 0.06, group B=0.349 ± 0.06) (p=0.004). Conclusion: Correlation of FA values with fibrosis stage and significant difference in FA values between early-late stage fibrosis patients shows that diffusion tensor imaging can be a promising technique in the staging and follow-up of liver fibrosis.

🔖

Cite This Article

Erturk, S. M., Basak, M., Ozguven, B. Y., Mut, D. T., Alkim, C. A., Alkim, H., Boga, S., Soylemez, U. P. O. (2022). The Efficiency of Fractional Anisotropy, Apparent Diffusion Coefficient, and Contrast Enhancement Index in Liver Fibrosis Staging. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 56 - Sayı: 1, 113–118. https://ajindex.com/articles/594597

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. . Xiao H, Shi M, Xie Y, Chi X. Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: A systematic review and meta-analysis. PLoS One 2017
  2. e0186660. 2. Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatol- ogy 2018
  3. 1560–99. 3. Li X, Liu H, Wang R, Yang J, Zhang Y, Li C. Gadoxetate-disodium- enhanced magnetic resonance imaging for liver fibrosis staging: a systematic review and meta-analysis. Clin Radiol 2020
  4. Esmaeelzadeh A, Saadatnia H, Memar B, Mokhtari Amirmajdi E, Ganji A, Goshayeshi L, et al. Evaluation of serum HBV viral load, transaminases and histological features in chronic HBeAg- negative hepatitis B patients. Gastroenterol Hepatol Bed Bench 2017
  5. 39–43. 5. Lambrecht J, Verhulst S, Mannaerts I, Reynaert H, van Grunsven LA. Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future gold standard? Biochim Biophys Acta Mol Basis Dis 2018
  6. 1024–36. 6. Zhong X, Li JS, Chen ZJ, Yin JX, Gui S, Sun ZQ, et al. Texture analy- sis of diffusion-weighted magnetic resonance imaging to iden- tify atypically enhanced small hepatocellular carcinoma and dysplastic nodules under the background of cirrhosis. [Article in Chinese]. Zhonghua Gan Zang Bing Za Zhi 2020
  7. 37–42. 7. Jiang H, Chen J, Gao R, Huang Z, Wu M, Song B. Liver fibrosis stag- ing with diffusion-weighted imaging: a systematic review and meta-analysis. Abdom Radiol (NY) 2017
  8. 490–501. 8. Bharwani N, Koh DM. Diffusion-weighted imaging of the liver: an update. Cancer Imaging 2013
  9. 171–85. 9. Verloh N, Utpatel K, Haimerl M, Zeman F, Beyer L, Fellner C, et al. Detecting liver fibrosis with Gd-EOB-DTPA-enhanced MRI: A con- firmatory study. Sci Rep 2018
  10. Tamada T, Ito K, Higaki A, Yoshida K, Kanki A, Sato T, et al. Gd-EOB- DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur J Radiol 2011
  11. e311–6. 11. Hako R, Kristian P, Jarčuška P, Haková I, Hockicková I, Schréter I, e al. Noninvasive assessment of liver fibrosis in patients with chron- ic hepatitis B or C by contrast-enhanced magnetic resonance im- aging. Can J Gastroenterol Hepatol 2019
  12. 3024630. 12. Ishak KG. Pathologic features of chronic hepatitis. A review and update. Am J Clin Pathol 2000
  13. 40–55. 13. Aydın MM, Ak